Statins Archives - PharmaLive

FDA Approves Esperion’s Nexlizet for Lowering LDL Cholesterol

"Bad" LDL Cholesterol, Approvals, Atherosclerotic Cardiovascular Disease (ASCVD), Cholesterol Lowering, FDA, FDA/Regulatory, Fixed-Dose Combinations (FDCs), Non-statins, Statins

The U.S. Food and Drug Administration approved Ann Arbor, Michigan-based Esperion’s Nexlizet (bempedoic acid and ezetimibe) for lowering LDL cholesterol.

FDA approves expanded label for Praluent

"Bad" LDL Cholesterol, Approvals, Biotech, Cardiovascular Events, Cholesterol, Drug Pricing, Expanded Label, FDA, FDA/Regulatory, Heart Attacks, Heterozygous Familial Hypercholesterolemia (HeFH), Injectables, Major Adverse Cardiovascular Events (MACE), PCSK9 inhibitors, Statins, Stroke

The U.S. Food and Drug Administration approved Regeneron Pharmaceuticals’ cholesterol drug Praluent as a treatment to cut the risk of heart attacks, stroke and other major cardiovascular events.

Celltrion Signs ‘Incubation’ Agreement with Emory University for Development of New Drugs for Atherosclerosis

Atherosclerosis, Biologics, Biopharmaceutical, Blood Vessels, Business, Cholesterol Lowering, Contract Development Manufacturing Organization (CDMO), Incubators, Innovation, Plaque, R&D, Statins, Vascular DIsease

Celltrion Inc. signed an ‘Incubation’ agreement with Emory University in Atlanta to support the research and development of new drug candidates for atherosclerosis.